Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Cash from Operations (2016 - 2021)

Phio Pharmaceuticals' Cash from Operations history spans 10 years, with the latest figure at 2471000.0 for Q4 2021.

  • For Q4 2021, Cash from Operations rose 5.79% year-over-year to 2471000.0; the TTM value through Dec 2021 reached 11858000.0, down 34.72%, while the annual FY2025 figure was 7979000.0, 12.19% down from the prior year.
  • Cash from Operations reached 2471000.0 in Q4 2021 per PHIO's latest filing, up from 2866000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1746000.0 in Q4 2018 to a low of 3266000.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 2316950.0, with a median of 2186500.0 recorded in 2017.
  • Peak YoY movement for Cash from Operations: tumbled 60.42% in 2017, then skyrocketed 31.87% in 2018.
  • A 5-year view of Cash from Operations shows it stood at 2201000.0 in 2017, then increased by 20.67% to 1746000.0 in 2018, then plummeted by 45.82% to 2546000.0 in 2019, then decreased by 3.02% to 2623000.0 in 2020, then increased by 5.79% to 2471000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Cash from Operations are 2471000.0 (Q4 2021), 2866000.0 (Q3 2021), and 3255000.0 (Q2 2021).